Kip Martin joined Columbia as Vice President, Business Development in May 2011. He is an experienced business development executive with over 15 completed transactions over the past ten years. Mr. Martin was previously a business development consultant to the Company, and as such was instrumental in the April 2011 sale of STRIANT® (testosterone buccal system) to Actient Pharmaceuticals and the expansion of Columbia's relationship with The Urology Company for STRIANT to include all of Europe. He formerly consulted on business development and fundraising activities for Inspirion Delivery Techonologies, a privately-held drug delivery company developing abuse-deterrent opioids. Prior to that, he was Director of Corporate and Business Development at Alpharma, Inc., before which Mr. Martin was Director of Business Development of Reliant Pharmaceuticals. He began his career as a Consultant with The Wilkerson Group. Mr. Martin holds an MBA in finance from Yale University and a BS with honors in engineering from Case Western Reserve University.
